Improving patient outcomes with regenerative medicine: How to move the needle forward in cell manufacturing, standards, 3D bioprinting, AI enabled automation, education and training

Published

June 17, 2020

Author(s)

Carl Simon Jr., Josh Hunsberger, Claudia Zylberberg, Preveen Ramamoorthy, Thomas Tubon, Crystal Ruff, Ram Bedi, Kurt Gielen, Lynn Fisher, Jed Johnson, Priya Barankiak, Behzad Mahdavi, Michael Hadjisavas, Shannon Eaker, Cameron Miller

Abstract

Regenerative Medicine Manufacturing Society (RMMS), is the first and only professional society dedicated specifically towards advancing manufacturing solutions for the field of regenerative medicine. RMMS' vision is to provide greater patient access to regenerative medicine therapies through innovative manufacturing solutions. Our mission is to identify unmet needs and gaps in regenerative medicine manufacturing and catalyze the generation of new ideas and solutions by parting with private and public stakeholders. We aim to accomplish our mission through outreach and education programs and securing grants for public-private collaborations in regenerative medicine manufacturing. This perspective article will cover four impact areas that the society's leadership team has identified as critical, which include: (a) cell manufacturing and scale up/out respectively for allogeneic and autologous cell therapies, (b) standards, (c) 3D bioprinting, and (d) artificial intelligence -enabled automation (AI). In addition to covering these areas and ways in which the society intends to advance the field in a collaborative nature, we will also discuss education and training. This is an area that is critical for communicating the current challenges, developing solutions to accelerate the commercialization of the latest technological advances, as well as, growing the work force in this rapidly expanding sector of regenerative medicine.

Citation

Journal of Biomedical Materials Research Part B-Applied Biomaterials

Pub Type

Journals

Download Paper

DOI Link

Keywords

regenerative medicine, biomanufacturing, standards, additive manufacturing

Citation

Simon Jr., C. , Hunsberger, J. , Zylberberg, C. , Ramamoorthy, P. , Tubon, T. , Ruff, C. , Bedi, R. , Gielen, K. , Fisher, L. , Johnson, J. , Barankiak, P. , Mahdavi, B. , Hadjisavas, M. , Eaker, S. and Miller, C. (2020), Improving patient outcomes with regenerative medicine: How to move the needle forward in cell manufacturing, standards, 3D bioprinting, AI enabled automation, education and training, Journal of Biomedical Materials Research Part B-Applied Biomaterials, [online], https://doi.org/10.1002/sctm.19-0389 (Accessed April 24, 2024)